HKG: 2216

Broncus Medical Secures NMPA Fast‑Track for BroncTarget COPD System, Targeting 9 Million Refractory Patients in China

Broncus Medical (HKG: 2216) announced that China’s National Medical Products Administration (NMPA) has granted fast‑track designation...

Company Deals

Broncus Medical Acquires Valgen Stake from Venus for $15 Million

Fineline Cube Dec 30, 2025

Broncus Medical (HKG: 2216) announced that its wholly‑owned subsidiary, Broncus China Holding Corporation, has agreed...

Company Medical Device

Broncus Medical Wins NMPA Approval for BroncAblate RFA System Console

Fineline Cube Jun 24, 2025

Shanghai and Hangzhou (China), and San Jose and Seattle (United States)-based Broncus Medical (HKG: 2216)...

Company Medical Device

Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment

Fineline Cube Apr 22, 2025

Broncus Medical Inc. (HKG: 2216), a provider of precision intervention solutions for lung disease, announced...

Company

Broncus Medical Inc. Reports 32% YOY Growth in 2023, Highlighted by Strength in China

Fineline Cube Mar 29, 2024

Broncus Medical Inc. (HKG: 2216), a provider of precision intervention solutions for lung diseases with...

Company Deals

Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee

Fineline Cube Nov 27, 2023

Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...

Company Deals

Broncus Medical Inc. to Acquire Fibernova Holding Corporation for USD 2.7 Million

Fineline Cube Sep 11, 2023

Broncus Medical Inc., (HKG: 2216) a provider of lung disease precision intervention solutions with operations...

Company Medical Device

Broncus Medical Inc. Launches First Regulatory Clinical Study for Targeted Lung Denervation System

Fineline Cube Jul 10, 2023

China-based Broncus Medical Inc., (HKG: 2216), a provider of precision intervention solutions focused on lung...

Company Deals

Broncus Medical and Venus Medtech Establish Joint Venture Fund for Digital Medical Equipment

Fineline Cube Mar 29, 2023

Broncus Medical Inc., (HKG: 2216) a leading provider of lung disease precision intervention solutions based...

HKG: 2216

Broncus Medical Secures NMPA Fast‑Track for BroncTarget COPD System, Targeting 9 Million Refractory Patients in China

Broncus Medical Acquires Valgen Stake from Venus for $15 Million

Broncus Medical Wins NMPA Approval for BroncAblate RFA System Console

Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment

Broncus Medical Inc. Reports 32% YOY Growth in 2023, Highlighted by Strength in China

Broncus Medical and Hangzhou Norchant Terminate Licensing Agreement with Cancellation Fee

Broncus Medical Inc. to Acquire Fibernova Holding Corporation for USD 2.7 Million

Broncus Medical Inc. Launches First Regulatory Clinical Study for Targeted Lung Denervation System

Broncus Medical and Venus Medtech Establish Joint Venture Fund for Digital Medical Equipment

You Missed

Biogen’s High‑Dose SPINRAZA Wins EU Approval for 5q SMA After Japan Nod

InventisBio Files for Hong Kong IPO, Betting on Oncology and Metabolic Pipeline

Boston Scientific to Acquire Penumbra in $14.5 Billion Deal, Bolsters Thrombectomy Leadership

Gan & Lee’s Insulin Glargine Wins Ethiopia Approval, Challenging Sanofi’s Dominance